Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

ClinicalTrials.gov ID: NCT00055484

Public ClinicalTrials.gov record NCT00055484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.

Study identification

NCT ID
NCT00055484
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Elan Pharmaceuticals
Industry
Enrollment
204 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2002 (Type not available)
Primary completion
Not listed
Completion
May 2003 (Actual)
Last update posted
Dec 14, 2015

2002 – 2003

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Medical Affiliated Research Center Huntsville Alabama 35801 —
University of South Alabama Medical Ctr Department of Neurology Mobile Alabama 36693 —
Valley Neurological Headache Clinic Phoenix Arizona 85020 —
The New England Center for Headache Stamford Connecticut 06902 —
Radiant Research Overland Park Kansas 66215 —
Michigan Head-Pain & Neurological Institute Ann Arbor Michigan 48104 —
Mercy Health Research Chesterfield Missouri 63017 —
Headache Care Center Springfield Missouri 65804 —
Neurological Associates of Tulsa Tulsa Oklahoma 74136 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
MetaClin Research Austin Texas 19107 —
Houston Headache Clinic Houston Texas 77004 —
Radiant Research Salt Lake City Utah 84111 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00055484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 14, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00055484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →